114 related articles for article (PubMed ID: 16890442)
1. Pore-forming scissors? A first structural glimpse of gamma-secretase.
Steiner H; Than M; Bode W; Haass C
Trends Biochem Sci; 2006 Sep; 31(9):491-3. PubMed ID: 16890442
[TBL] [Abstract][Full Text] [Related]
2. The Alzheimer's disease-associated gamma-secretase complex: functional domains in the presenilin 1 protein.
Laudon H; Winblad B; Näslund J
Physiol Behav; 2007 Sep; 92(1-2):115-20. PubMed ID: 17588625
[TBL] [Abstract][Full Text] [Related]
3. Abeta 11-40/42 production without gamma-secretase epsilon-site cleavage.
Kume H; Kametani F
Biochem Biophys Res Commun; 2006 Nov; 349(4):1356-60. PubMed ID: 16979587
[TBL] [Abstract][Full Text] [Related]
4. Secretase inhibitors and modulators for Alzheimer's disease treatment.
Tomita T
Expert Rev Neurother; 2009 May; 9(5):661-79. PubMed ID: 19402777
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenesis of Alzheimer's disease: implications from amyloid research front].
Iwatsubo T
Rinsho Shinkeigaku; 2004 Nov; 44(11):768-70. PubMed ID: 15651286
[TBL] [Abstract][Full Text] [Related]
7. The structure and function of Alzheimer's gamma secretase enzyme complex.
Krishnaswamy S; Verdile G; Groth D; Kanyenda L; Martins RN
Crit Rev Clin Lab Sci; 2009; 46(5-6):282-301. PubMed ID: 19958215
[TBL] [Abstract][Full Text] [Related]
8. Gamma-secretase: a complex target for Alzheimer's disease.
Lundkvist J; Näslund J
Curr Opin Pharmacol; 2007 Feb; 7(1):112-8. PubMed ID: 17169612
[TBL] [Abstract][Full Text] [Related]
9. Regulation of gamma-secretase activity in Alzheimer's disease.
Zhou S; Zhou H; Walian PJ; Jap BK
Biochemistry; 2007 Mar; 46(10):2553-63. PubMed ID: 17298085
[TBL] [Abstract][Full Text] [Related]
10. Pathological activity of familial Alzheimer's disease-associated mutant presenilin can be executed by six different gamma-secretase complexes.
Shirotani K; Tomioka M; Kremmer E; Haass C; Steiner H
Neurobiol Dis; 2007 Jul; 27(1):102-7. PubMed ID: 17560791
[TBL] [Abstract][Full Text] [Related]
11. Rapid purification of active gamma-secretase, an intramembrane protease implicated in Alzheimer's disease.
Cacquevel M; Aeschbach L; Osenkowski P; Li D; Ye W; Wolfe MS; Li H; Selkoe DJ; Fraering PC
J Neurochem; 2008 Jan; 104(1):210-20. PubMed ID: 17986218
[TBL] [Abstract][Full Text] [Related]
12. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
[TBL] [Abstract][Full Text] [Related]
13. Excess of nicastrin in brain results in heterozygosity having no effect on endogenous APP processing and amyloid peptide levels in vivo.
Brijbassi S; Amtul Z; Newbigging S; Westaway D; St George-Hyslop P; Rozmahel RF
Neurobiol Dis; 2007 Feb; 25(2):291-6. PubMed ID: 17071095
[TBL] [Abstract][Full Text] [Related]
14. Building gamma-secretase: the bits and pieces.
Spasic D; Annaert W
J Cell Sci; 2008 Feb; 121(Pt 4):413-20. PubMed ID: 18256384
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the lipidation of beta-secretase by statins.
Parsons RB; Farrant JK; Price GC; Subramaniam D; Austen BM
Biochem Soc Trans; 2007 Jun; 35(Pt 3):577-82. PubMed ID: 17511656
[TBL] [Abstract][Full Text] [Related]
16. Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease.
Hampel H; Shen Y
Scand J Clin Lab Invest; 2009; 69(1):8-12. PubMed ID: 18609117
[TBL] [Abstract][Full Text] [Related]
17. Why does beta-secretase zymogen possess catalytic activity? Molecular modeling and molecular dynamics simulation studies.
Zuo Z; Gang C; Zou H; Mok PC; Zhu W; Chen K; Jiang H
Comput Biol Chem; 2007 Jun; 31(3):186-95. PubMed ID: 17500040
[TBL] [Abstract][Full Text] [Related]
18. Update on amyloid-beta homeostasis markers for sporadic Alzheimer's disease.
Zetterberg H
Scand J Clin Lab Invest; 2009; 69(1):18-21. PubMed ID: 19199126
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease sends the wrong signals--a perspective.
Neve RL
Amyloid; 2008 Mar; 15(1):1-4. PubMed ID: 18266116
[TBL] [Abstract][Full Text] [Related]
20. 1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.
Imbimbo BP; Del Giudice E; Colavito D; D'Arrigo A; Dalle Carbonare M; Villetti G; Facchinetti F; Volta R; Pietrini V; Baroc MF; Serneels L; De Strooper B; Leon A
J Pharmacol Exp Ther; 2007 Dec; 323(3):822-30. PubMed ID: 17895400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
